Investor List:

Top Pharmaceuticals Seed Investors (1269)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Vijay Pande, General Partner at Andreessen Horowitz
Vijay Pande
Andreessen Horowitz·General Partner
Sweet spot: $100K
Range: $100K - $10.0M
Investors in Menlo Park (CA)
Photo of Robert Garland, President at CrowdQuest
Robert Garland
CrowdQuest·President
Sweet spot: $25.0M
Range: $2.0M - $50.0M
Investors in SF Bay Area (CA), Investors in San Francisco (CA)
Photo of Bill Helman, Partner at Greylock
Bill Helman
Greylock·Partner
Sweet spot: $25.0M
Range: $500K - $200.0M
Investors in Boston (MA)
Photo of Jake Nunn, Venture Partner at SR One Capital Management
Jake Nunn
SR One Capital Management·Venture Partner
Sweet spot: $25.0M
Range: $50K - $50.0M
Investors in Menlo Park (CA)
Photo of Alex Kopelyan, Partner at SOSV
Alex Kopelyan
SOSV·Partner
Sweet spot: $250K
Range: $250K - $250K
Investors in United States, Investors in San Francisco (CA), Investors in SF Bay Area (CA)
Photo of Parikshit Sharma, Partner at SOSV
Parikshit Sharma
SOSV·Partner
Sweet spot: $250K
Range: $250K - $500K
Investors in SF Bay Area (CA), Investors in San Francisco (CA)
Investors in AgTech (Series B), Investors in Material Science (Seed), Investors in Medical Devices (Seed), Investors in AgTech (Series A), Investors in Consumer Health (Series B), Investors in Impact (Seed), Investors in Pharmaceuticals (Seed), Investors in AgTech (Seed), Investors in Food and Beverage (Seed), Investors in BioTech (Series B), Investors in EnergyTech (Series B), Investors in Consumer Health (Series A), Investors in EnergyTech (Seed), Investors in Food and Beverage (Series B), Investors in EnergyTech (Series A), Investors in Impact (Series B), Investors in Food and Beverage (Series A), Investors in Medical Devices (Series B), Investors in Impact (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in Consumer Health (Seed), Investors in Material Science (Series B), Investors in Material Science (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Diverse Investors (Other Lists), Investors in Health & Hospital Services (Series B), Investors in AgTech (Seed), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in EnergyTech (Seed), Investors in Food and Beverage (Seed), Investors in Health & Hospital Services (Series A), Investors in Impact (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Material Science (Seed), Investors in Pharmaceuticals (Seed), Investors in AgTech (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in EnergyTech (Series A), Investors in Impact (Series A), Investors in Food and Beverage (Series A), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Series A), Investors in Material Science (Series A), Investors in Pharmaceuticals (Series A), Investors in Consumer Health (Series B), Investors in EnergyTech (Series B), Investors in AgTech (Series B), Investors in BioTech (Series B), Investors in Food and Beverage (Series B), Investors in Impact (Series B), Investors in Health & Hospital Services (Series B), Investors in Material Science (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Impact (Pre-seed), Investors in AgTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Material Science (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in AgTech (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Impact (Pre-seed), Investors in EnergyTech (Pre-seed), Investors in Food and Beverage (Pre-seed), Investors in BioTech (Pre-seed), Investors in Material Science (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health & Hospital Services (Seed)
Photo of Shahram Seyedin-Noor, General Partner at Civilization Ventures
Shahram Seyedin-Noor
Civilization Ventures·General Partner
Sweet spot: $1M
Range: $50K - $10.0M
Investors in SF Bay Area (CA)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Health IT (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Health IT (Pre-seed), Investors in BioTech (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Pre-seed), Investors in Health & Hospital Services (Seed)
Photo of Kunal Sethi, General Partner at Prithvi Ventures
Kunal Sethi
Prithvi Ventures·General Partner
Sweet spot: $1M
Range: $400K - $9.5M
Investors in Singapore, Investors in United Kingdom, Investors in Melbourne (Australia), Investors in Canada, Investors in United States, Investors in Europe
Investors in AgTech (Series A), Investors in AgTech (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Seed), Investors in EnergyTech (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in AgTech (Seed), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in BioTech (Seed), Investors in Investors who invested in diverse founders (Other Lists), Investors in ClimateTech/CleanTech (Seed), Investors in EnergyTech (Seed), Investors in New York City (Other Lists), Investors in AgTech (Series A), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in EnergyTech (Series A), Investors in Canada (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in DeepTech (Seed), Investors in DeepTech (Series A), Investors in DeepTech (Series A), Investors in DeepTech (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Chemicals (Series A), Investors in Chemicals (Seed), Investors in Drug Delivery (Seed), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Chemicals (Seed), Investors in Chemicals (Series A), Investors in Medical Devices (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Series A)
Get new data & insights delivered to your inbox
Firms investing in this space